Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan · Delayed Price · Currency is TWD 78.90
-2.60 (-3.19%)
Jul 29, 2026, 1:30 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 9.56 billion as of July 29, 2026. Its market cap has decreased by -21.62% in one year.
Market Cap
9.56B
Enterprise Value
8.15B
Revenue
38.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
78.90
ChartMarket Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 9.56B, an increase of 7.86%. That is a compound annual growth rate of 0.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 9.56B | -9.42% |
| Dec 31, 2025 | 10.56B | -26.53% |
| Dec 31, 2024 | 14.37B | -31.28% |
| Dec 29, 2023 | 20.91B | -42.13% |
| Dec 30, 2022 | 36.13B | 16.16% |
| Dec 30, 2021 | 31.10B | 17.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EirGenix | 13.89B |
| ACRO Biomedical | 13.32B |
| TCM Biotech International | 10.69B |
| Tanvex BioPharma | 10.02B |
| Polaris Group | 9.93B |
| PharmaEngine | 9.14B |
| AP Biosciences | 8.61B |
| Locus Cell | 7.60B |